Hyperactivity induced by prenatal BrdU exposure across several experimental conditions

Makiko Kuwagata1, Tetsuo Ogawa, Katsumasa Muneoka

  • 1Laboratory of Pathology, Division of Toxicology, Hatano Research Institute, Food and Drug Safety Center, Kanagawa. kuwagata.m@fdsc.or.jp

Congenital Anomalies
|November 23, 2011
PubMed
Summary

Bromodeoxyuridine (BrdU)-induced hyperactivity is a reproducible positive control in developmental neurotoxicity (DNT) testing across various conditions. This finding validates the BrdU-animal model for ensuring the reliability of DNT test processes.